Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 PandemicArticle Published on 2023-02-012023-07-10 Journal: Journal of community health [Category] COVID19(2023년), [키워드] antibody duration Long-term care facility neutralizing antibody SARS-CoV-2 Vaccine response. [DOI] 10.1007/s10900-022-01142-z PMC 바로가기
Human antibody BD-218 has broad neutralizing activity against concerning variants of SARS-CoV-2Article Published on 2023-02-012023-07-11 Journal: International journal of biological macromolecules [Category] COVID19(2023년), [키워드] neutralizing antibody SARS-CoV-2. [DOI] 10.1016/j.ijbiomac.2022.12.120 PMC 바로가기
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodiesArticle Published on 2023-01-102023-07-11 Journal: Immunity [Category] COVID19(2023년), [키워드] copy-number variation immunoglobulin allelic diversity neutralizing antibody SARS-CoV-2 Single-nucleotide polymorphism. [DOI] 10.1016/j.immuni.2022.12.005 PMC 바로가기
High titers of neutralizing antibodies in the blood fail to eliminate SARS-CoV-2 viral RNA in the upper respiratory tractArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] neutralizing antibody vaccination viral RNA-positive retest. [DOI] 10.1002/jmv.28219 PMC 바로가기
Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infectionArticle Published on 2022-12-272023-07-10 Journal: Journal of Travel Medicine [Category] COVID19(2023년), [키워드] Anti-S1-IgA mRNA vaccines neutralizing antibody SRBD-IgM waning. [DOI] 10.1093/jtm/taac130 PMC 바로가기
Symptomatic and Asymptomatic SARS-CoV-2 Infection and Follow-up of Neutralizing Antibody LevelsArticle Published on 2022-12-202023-07-11 Journal: Biomedical and environmental sciences : BES [Category] COVID19(2023년), [키워드] Asymptomatic neutralizing antibody SARS-CoV-2 symptomatic. [DOI] 10.3967/bes2022.139 PMC 바로가기
Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens4가지 프라이밍-부스팅 요법으로 유발된 SARS-CoV-2 변이체에 대한 중화 항체의 일대일 비교Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] comparison elicited neutralizing antibody regimen SARS-CoV-2 variant [DOI] 10.1080/22221751.2022.2095931 PMC 바로가기 [Article Type] Article
Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variantsArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Administered Antibody neutralization BBIBP-CorV Beta booster vaccination circulating CoronaVac coronavirus Delta Eta Gamma humoral immune response immune immune response inactivated Inactivated vaccine individual Lineage lineages morbidity and mortality Mutation neutralization neutralization titer neutralize neutralized Neutralizing Neutralizing antibodies neutralizing antibody Neutralizing antibody response omicron reduce SARS-CoV-2 SARS-CoV-2 variant second vaccination serum sample significantly lower the SARS-CoV-2 vaccine dose variant viral variant Viral variants Viral variants. virus virus strain viruses wild-type [DOI] 10.1002/jmv.28049 PMC 바로가기
Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccinesArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Ad26.COV2.S Ad26.COV2.S vaccine antibody B.1.1.529 B.1.1.7 B.1.351 B.1.617.2 Beta BNT162b2 BNT162b2 vaccine booster center contributed Control COVID-19 Delta dose Effectiveness elicited faster FIVE Gamma immunization moderate mRNA-1273 mRNA-based vaccine Mutation Neutralizing Neutralizing antibodies neutralizing antibody omicron P.1 postvaccination prevention Protein pseudovirus receiving recipient recommendation robust SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 variant subject Support vaccination Vaccine vaccine efficacy variants of concern variants of concern (VOCs). VoC VOCs wild type [DOI] 10.1002/jmv.28032 PMC 바로가기
Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome antibody asymptomatic infections benefit blood sample booster dose Clinical severity collected coronavirus coronavirus disease COVID-19 COVID-19 vaccination detectable dose evaluated Evidence first dose humoral humoral immune response Humoral immunity Humoral response inactivated Inactivated COVID-19 vaccine individual individuals infected individuals Infection median mild cases moderate multicenter NAb titer NAbs naïve individual naïve individuals natural infection Neutralizing Neutralizing activity neutralizing antibody omicron pan-immunoglobulins. participant prospective cohort study Protein receive recovered patient SARS-CoV-2 second dose seroconversion rate severity significantly single dose single vaccine the vaccine U/mL vaccination variant [DOI] 10.1002/jmv.28055 PMC 바로가기